(2003). Cost-of-illness analyses for policy making: a cautionary tale of use and misuse. Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 3, No. 4, pp. 367-369.
No takes yet. Share an insight, caveat, or question.
Finkelstein et al. (2003) studied this question.